Jolyon Mitchell has long been a leading voice in OINDP development and analysis through numerous publications and through service to multiple organizations, including … [Read more...] about A Q&A with Jolyon Mitchell — Part 2
Features
Looking back at RDD Europe 2013
Weeks after the conclusion of RDD Europe 2013 in Berlin, organizers RDD Online and Aptar Pharma are still wrapping up logistical loose ends and analyzing delegate feedback, says Pierre Carlotti of Aptar Pharma. OINDP specialists from 29 countries attended the meeting, with an increase in European delegates, especially from Southern and Eastern Europe, and a slight … [Read more...] about Looking back at RDD Europe 2013
A Q&A with Jolyon Mitchell — Part 1
Jolyon Mitchell has long been a leading voice in OINDP development and analysis through numerous publications and through service to multiple organizations, including … [Read more...] about A Q&A with Jolyon Mitchell — Part 1
RDD Europe 2013 — Day 3
Despite most delegates having partied past midnight at the previous night's gala dinner, the 8:30 a.m. session on "Designing Devices for the Marketplace” Day 3 of RDD Europe 2013 was very well attended. Presentations in the session covered design issues for both patient and regulatory concerns, including discussions of the Asthmapolis monitoring system, the … [Read more...] about RDD Europe 2013 — Day 3
RDD Europe 2013 — Day 2
On Day 2 of RDD Europe 2013, the focus was primarily on regulatory issues. Prior to sessions titled “Weighing the Evidence in Support of Bioequivalence,” “Orphan Drugs: Opportunities and Regulatory and Clinical Challenges,” and “Harmonizing the Clinical Requirements for LABA/ICS Combinations in the USA and Europe,” however, the day opened with a “Posters on the … [Read more...] about RDD Europe 2013 — Day 2
RDD Europe 2013 — Day 1
On the morning of May 22, one of the organizers of RDD Europe 2013, Peter Byron, opened the meeting by welcoming approximately 470 delegates back to Berlin. According to Byron, 87% of the delegates come from the pharmaceutical industry and 10% are academics, plus a small number of regulators. Delegates have arrived from more than 31 countries, with almost 70% from … [Read more...] about RDD Europe 2013 — Day 1
ISAM 2013 Day 3
In addition to scientific sessions, Day 3 of ISAM 2013 included awards presentations and the organization's general assembly meeting. During the awards ceremony, Bill Bennett presented the Jurai Ferin award to Patrice Diot of the University Hospital of Tours, France. Along with the certificate of recognition, Diot received the gift of a balloon trip over the Loire … [Read more...] about ISAM 2013 Day 3
ISAM 2013 Day 2
The first session of Day 2 of the 2013 ISAM Congress concerned “Aerosol Deposition at the Extremes: Exploring the Limits with Novel Methodologies,” and the most extreme study presented looked at “Aerosol Deposition in Reduced Gravity.” Chantal Darquenne of UCSD described experiments conducted in large part aboard NASA's parabolic aircraft to study questions related to … [Read more...] about ISAM 2013 Day 2
ISAM 2013 Day 1
On the first full day of the International Society of Aerosol Medicine (ISAM) 2013 Congress, Congress Chair Bill Bennett welcomed approximately 330 delegates to the University of North Carolina, Chapel Hill. Many of the delegates had already attended ISAM events on Saturday, including three pre-Congress workshops and a welcome reception. More than 50 people … [Read more...] about ISAM 2013 Day 1
RDD Europe returns to Berlin
Delegates to RDD Europe 2013, which takes place May 21-24, will notice familiar features from past iterations of the event alongside several innovations designed to enhance the meeting experience. The most obvious familiar element of RDD Europe 2013 is the location, the Intercontinental Hotel in Berlin Germany, which also hosted RDD Europe 2011. Co-organizers RDD … [Read more...] about RDD Europe returns to Berlin